These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 30176511)
21. Polyester-based nanoparticles for nucleic acid delivery. Zhao J; Weng G; Li J; Zhu J; Zhao J Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():983-994. PubMed ID: 30184828 [TBL] [Abstract][Full Text] [Related]
22. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography. Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593 [TBL] [Abstract][Full Text] [Related]
23. Targeted Alpha Therapy and Nanocarrier Approach. Silindir-Gunay M; Karpuz M; Ozer AY Cancer Biother Radiopharm; 2020 Aug; 35(6):446-458. PubMed ID: 32302510 [TBL] [Abstract][Full Text] [Related]
24. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance. Bar-Zeev M; Livney YD; Assaraf YG Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241 [TBL] [Abstract][Full Text] [Related]
25. Anticancer use of nanoparticles as nucleic acid carriers. Gozuacik D; Yagci-Acar HF; Akkoc Y; Kosar A; Dogan-Ekici AI; Ekici S J Biomed Nanotechnol; 2014 Sep; 10(9):1751-83. PubMed ID: 25992440 [TBL] [Abstract][Full Text] [Related]
28. Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Masood F Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():569-578. PubMed ID: 26706565 [TBL] [Abstract][Full Text] [Related]
29. Membrane-core nanoparticles for cancer nanomedicine. Guo J; Huang L Adv Drug Deliv Rev; 2020; 156():23-39. PubMed ID: 32450105 [TBL] [Abstract][Full Text] [Related]
30. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Acharya S; Sahoo SK Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219 [TBL] [Abstract][Full Text] [Related]
31. Peptides for nucleic acid delivery. Lehto T; Ezzat K; Wood MJA; El Andaloussi S Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594 [TBL] [Abstract][Full Text] [Related]
33. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review. Sultana S; Khan MR; Kumar M; Kumar S; Ali M J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288 [TBL] [Abstract][Full Text] [Related]
34. Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier. Avila YI; Chandler M; Cedrone E; Newton HS; Richardson M; Xu J; Clogston JD; Liptrott NJ; Afonin KA; Dobrovolskaia MA Molecules; 2021 Jan; 26(3):. PubMed ID: 33513786 [TBL] [Abstract][Full Text] [Related]
35. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy. Mou Q; Ma Y; Zhu X; Yan D J Control Release; 2016 May; 230():34-44. PubMed ID: 27040815 [TBL] [Abstract][Full Text] [Related]
36. Nanomedicine: An effective tool in cancer therapy. Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746 [TBL] [Abstract][Full Text] [Related]